Micardis HCT 12.5 mg/1

Micardis HCT 12.5 mg/1 combines telmisartan and hydrochlorothiazide for blood pressure management. This oral tablet helps regulate hypertension with a dual-action formula.

Micardis HCT 12.5 mg/1 is primarily used for managing high blood pressure. The combination of telmisartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and reducing fluid retention. This medication is often prescribed for individuals who require dual therapy to achieve optimal blood pressure control.

Common effects of Micardis HCT 12.5 mg/1 may include dizziness, fatigue, and mild nausea. Some users might experience dehydration or electrolyte imbalances due to the diuretic component. It's important to stay hydrated and monitor for any unusual symptoms while taking this medication.

Micardis HCT 12.5 mg/1 should be handled with care, especially for those with kidney or liver issues. Regular monitoring of blood pressure and electrolyte levels is recommended. Avoid sudden changes in dosage without consulting a healthcare provider.

Micardis HCT 12.5 mg/1 may interact with other blood pressure medications, NSAIDs, and certain supplements. Alcohol consumption should be limited, as it can enhance the effects of the diuretic component. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.